A phase I oncolytic virus trial with vesicular stomatitis virus expressing human interferon beta and tyrosinase related protein 1 administered intratumorally and intravenously in uveal melanoma: safety, efficacy, and T cell responses.
Saved in:
| Title: | A phase I oncolytic virus trial with vesicular stomatitis virus expressing human interferon beta and tyrosinase related protein 1 administered intratumorally and intravenously in uveal melanoma: safety, efficacy, and T cell responses. |
|---|---|
| Authors: | Smith KER; Department of Medical Oncology, Mayo Clinic, Rochester, MN, United States., Peng KW; Department of Molecular Medicine, Mayo Clinic, Rochester, MN, United States., Pulido JS; Department of Ophthalmology, Wills Eye Hospital, Philadelphia, PA, United States., Weisbrod AJ; Department of Radiology, Mayo Clinic, Rochester, MN, United States., Strand CA; Department of Biostatistics and Informatics, Mayo Clinic, Rochester, MN, United States., Allred JB; Department of Biostatistics and Informatics, Mayo Clinic, Rochester, MN, United States., Newsom AN; Department of Molecular Medicine, Mayo Clinic, Rochester, MN, United States., Zhang L; Department of Molecular Medicine, Mayo Clinic, Rochester, MN, United States., Packiriswamy N; Department of Molecular Medicine, Mayo Clinic, Rochester, MN, United States., Kottke T; Department of Molecular Medicine, Mayo Clinic, Rochester, MN, United States., Tonne JM; Department of Molecular Medicine, Mayo Clinic, Rochester, MN, United States., Moore M; Department of Molecular Medicine, Mayo Clinic, Rochester, MN, United States., Montane HN; Department of Medical Oncology, Mayo Clinic, Rochester, MN, United States., Kottschade LA; Department of Medical Oncology, Mayo Clinic, Rochester, MN, United States., McWilliams RR; Department of Medical Oncology, Mayo Clinic, Rochester, MN, United States., Dudek AZ; Department of Medical Oncology, Mayo Clinic, Rochester, MN, United States., Yan Y; Department of Hematology and Oncology, Mayo Clinic Florida, Jacksonville, FL, United States., Dimou A; Department of Medical Oncology, Mayo Clinic, Rochester, MN, United States., Markovic SN; Department of Medical Oncology, Mayo Clinic, Rochester, MN, United States., Federspiel MJ; Department of Molecular Medicine, Mayo Clinic, Rochester, MN, United States., Vile RG; Department of Molecular Medicine, Mayo Clinic, Rochester, MN, United States., Dronca RS; Department of Hematology and Oncology, Mayo Clinic Florida, Jacksonville, FL, United States., Block MS; Department of Medical Oncology, Mayo Clinic, Rochester, MN, United States. |
| Source: | Frontiers in immunology [Front Immunol] 2023 Oct 31; Vol. 14, pp. 1279387. Date of Electronic Publication: 2023 Oct 31 (Print Publication: 2023). |
| Publication Type: | Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38022659 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: A phase I oncolytic virus trial with vesicular stomatitis virus expressing human interferon beta and tyrosinase related protein 1 administered intratumorally and intravenously in uveal melanoma: safety, efficacy, and T cell responses. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Smith+KER%22">Smith KER</searchLink>; Department of Medical Oncology, Mayo Clinic, Rochester, MN, United States.<br /><searchLink fieldCode="AU" term="%22Peng+KW%22">Peng KW</searchLink>; Department of Molecular Medicine, Mayo Clinic, Rochester, MN, United States.<br /><searchLink fieldCode="AU" term="%22Pulido+JS%22">Pulido JS</searchLink>; Department of Ophthalmology, Wills Eye Hospital, Philadelphia, PA, United States.<br /><searchLink fieldCode="AU" term="%22Weisbrod+AJ%22">Weisbrod AJ</searchLink>; Department of Radiology, Mayo Clinic, Rochester, MN, United States.<br /><searchLink fieldCode="AU" term="%22Strand+CA%22">Strand CA</searchLink>; Department of Biostatistics and Informatics, Mayo Clinic, Rochester, MN, United States.<br /><searchLink fieldCode="AU" term="%22Allred+JB%22">Allred JB</searchLink>; Department of Biostatistics and Informatics, Mayo Clinic, Rochester, MN, United States.<br /><searchLink fieldCode="AU" term="%22Newsom+AN%22">Newsom AN</searchLink>; Department of Molecular Medicine, Mayo Clinic, Rochester, MN, United States.<br /><searchLink fieldCode="AU" term="%22Zhang+L%22">Zhang L</searchLink>; Department of Molecular Medicine, Mayo Clinic, Rochester, MN, United States.<br /><searchLink fieldCode="AU" term="%22Packiriswamy+N%22">Packiriswamy N</searchLink>; Department of Molecular Medicine, Mayo Clinic, Rochester, MN, United States.<br /><searchLink fieldCode="AU" term="%22Kottke+T%22">Kottke T</searchLink>; Department of Molecular Medicine, Mayo Clinic, Rochester, MN, United States.<br /><searchLink fieldCode="AU" term="%22Tonne+JM%22">Tonne JM</searchLink>; Department of Molecular Medicine, Mayo Clinic, Rochester, MN, United States.<br /><searchLink fieldCode="AU" term="%22Moore+M%22">Moore M</searchLink>; Department of Molecular Medicine, Mayo Clinic, Rochester, MN, United States.<br /><searchLink fieldCode="AU" term="%22Montane+HN%22">Montane HN</searchLink>; Department of Medical Oncology, Mayo Clinic, Rochester, MN, United States.<br /><searchLink fieldCode="AU" term="%22Kottschade+LA%22">Kottschade LA</searchLink>; Department of Medical Oncology, Mayo Clinic, Rochester, MN, United States.<br /><searchLink fieldCode="AU" term="%22McWilliams+RR%22">McWilliams RR</searchLink>; Department of Medical Oncology, Mayo Clinic, Rochester, MN, United States.<br /><searchLink fieldCode="AU" term="%22Dudek+AZ%22">Dudek AZ</searchLink>; Department of Medical Oncology, Mayo Clinic, Rochester, MN, United States.<br /><searchLink fieldCode="AU" term="%22Yan+Y%22">Yan Y</searchLink>; Department of Hematology and Oncology, Mayo Clinic Florida, Jacksonville, FL, United States.<br /><searchLink fieldCode="AU" term="%22Dimou+A%22">Dimou A</searchLink>; Department of Medical Oncology, Mayo Clinic, Rochester, MN, United States.<br /><searchLink fieldCode="AU" term="%22Markovic+SN%22">Markovic SN</searchLink>; Department of Medical Oncology, Mayo Clinic, Rochester, MN, United States.<br /><searchLink fieldCode="AU" term="%22Federspiel+MJ%22">Federspiel MJ</searchLink>; Department of Molecular Medicine, Mayo Clinic, Rochester, MN, United States.<br /><searchLink fieldCode="AU" term="%22Vile+RG%22">Vile RG</searchLink>; Department of Molecular Medicine, Mayo Clinic, Rochester, MN, United States.<br /><searchLink fieldCode="AU" term="%22Dronca+RS%22">Dronca RS</searchLink>; Department of Hematology and Oncology, Mayo Clinic Florida, Jacksonville, FL, United States.<br /><searchLink fieldCode="AU" term="%22Block+MS%22">Block MS</searchLink>; Department of Medical Oncology, Mayo Clinic, Rochester, MN, United States. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2023 Oct 31; Vol. 14, pp. 1279387. <i>Date of Electronic Publication: </i>2023 Oct 31 (<i>Print Publication: </i>2023). – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38022659 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fimmu.2023.1279387 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1279387 Titles: – TitleFull: A phase I oncolytic virus trial with vesicular stomatitis virus expressing human interferon beta and tyrosinase related protein 1 administered intratumorally and intravenously in uveal melanoma: safety, efficacy, and T cell responses. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Smith KER – PersonEntity: Name: NameFull: Peng KW – PersonEntity: Name: NameFull: Pulido JS – PersonEntity: Name: NameFull: Weisbrod AJ – PersonEntity: Name: NameFull: Strand CA – PersonEntity: Name: NameFull: Allred JB – PersonEntity: Name: NameFull: Newsom AN – PersonEntity: Name: NameFull: Zhang L – PersonEntity: Name: NameFull: Packiriswamy N – PersonEntity: Name: NameFull: Kottke T – PersonEntity: Name: NameFull: Tonne JM – PersonEntity: Name: NameFull: Moore M – PersonEntity: Name: NameFull: Montane HN – PersonEntity: Name: NameFull: Kottschade LA – PersonEntity: Name: NameFull: McWilliams RR – PersonEntity: Name: NameFull: Dudek AZ – PersonEntity: Name: NameFull: Yan Y – PersonEntity: Name: NameFull: Dimou A – PersonEntity: Name: NameFull: Markovic SN – PersonEntity: Name: NameFull: Federspiel MJ – PersonEntity: Name: NameFull: Vile RG – PersonEntity: Name: NameFull: Dronca RS – PersonEntity: Name: NameFull: Block MS IsPartOfRelationships: – BibEntity: Dates: – D: 31 M: 10 Text: 2023 Oct 31 Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 1664-3224 Numbering: – Type: volume Value: 14 Titles: – TitleFull: Frontiers in immunology Type: main |
| ResultId | 1 |
